Award recordCONTRACT

TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.

PIID VA503C00024· VHA· 503-ALTOONA· 6505 · DRUGS AND BIOLOGICALS· FY2010· $104,205 net obligations· UEI CRPPBSL435G7· NC

Description

PROLASTIN VLS 260 DOSAGES - ADDITIONAL PATIENT REQUIREMENTS

Base award description: PROLASTIN

First action · last action
2009-10-01 · 2010-12-07
Transactions
4
First transaction's obligation
$69,202
Base + all options value (sum of deltas)
$104,205
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$105,846$0Base award · 2009-10-01 · this action $69,202 · running total $69,202Modification 1 · 2010-06-07 · this action $18,000 · running total $87,202Modification 2 · 2010-08-19 · this action $18,644 · running total $105,846Modification 3 · 2010-12-07 · this action -$1,640 · running total $104,205
  • Base2009-10-01+$69,202= $69,202
  • Mod 12010-06-07+$18,000= $87,202
  • Mod 22010-08-19+$18,644= $105,846
  • Mod 32010-12-07-$1,640= $104,205
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2009-10-01+$69,202$69,202PROLASTIN
Mod 1· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2010-06-07+$18,000$87,202PROLASTIN VLS 260 DOSAGES - ADDITIONAL PATIENT REQUIREMENTS
Mod 2· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2010-08-19+$18,644$105,846PROLASTIN VLS 260 DOSAGES - ADDITIONAL PATIENT REQUIREMENTS
Mod 3· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2010-12-07−$1,640$104,205PROLASTIN VLS 260 DOSAGES - ADDITIONAL PATIENT REQUIREMENTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI CRPPBSL435G7)

AwardOffice · PSC / listingNet obligationsFY
VA25716J0121257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS$8,004FY2016
VA25115F2931515-BATTLE CREEK(00515) · Q999 · MEDICAL- OTHER$109,346FY2016
VA25715J3074257-NETWORK CONTRACT OFFICE 17 · 6505 · DRUGS AND BIOLOGICALS$7,880FY2015
VA25715J2849257-NETWORK CONTRACT OFFICE 17 · 6810 · CHEMICALS$3,881FY2015
VA24615F6283246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS$5,482FY2015
VA25715J1397671-SAN ANTONIO · 6505 · DRUGS AND BIOLOGICALS$7,344FY2015

Other recipients under 6505 from 503-ALTOONA (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24414F4202FISHER SCIENTIFIC COMPANY L.L.C.503-ALTOONA$9,542FY2014
VA24413F4115GRIFOLS THERAPEUTICS LLC503-ALTOONA$37,405FY2014
VA24413P2434ASD SPECIALTY HEALTHCARE, LLC503-ALTOONA$13,162FY2013
VA24413P1170ASD SPECIALTY HEALTHCARE, LLC503-ALTOONA$13,020FY2013
VA24412P2702MCKESSON CORPORATION503-ALTOONA$8,424FY2012

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA503C00024_3600_-NONE-_-NONE- · retrieved 2026-09-26.